Call Options Transactions Made in Q3 2023 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q3 2023. The information is specifically focused on institutions that hold call options of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
55.8K+ 18.97% |
$257K - $444K
|
350K
$966K
|
|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
30.2KNew |
$139K - $240K
|
30.2K
$83.4K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
5.8K+ 50.0% |
$26.7K - $46.1K
|
17.4K
$48K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-600- 40.0% |
$2.76K - $4.77K
|
900
$2.48K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-128K- 47.6% |
$587K - $1.02M
|
141K
$388K
|